Leukemia, Lymphocytic, Chronic, B-Cell
-
Subject Areas on Research
-
"Primum non nocere": the addition of granulocyte-macrophage colony stimulating factor to alemtuzumab in chronic lymphocytic leukemia.
-
5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen.
-
A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia.
-
A pathobiological role of the insulin receptor in chronic lymphocytic leukemia.
-
A single tube, four-color flow cytometry assay for evaluation of ZAP-70 and CD38 expression in chronic lymphocytic leukemia.
-
Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia.
-
Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.
-
Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia.
-
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia.
-
Axillary lymph nodes: mammographic, pathologic, and clinical correlation.
-
B-lymphoblastic leukemia in a patient with chronic lymphocytic leukemia: Sequential development of biclonal B-cell neoplasms over a 23-year period in a single individual.
-
CD38 variation as a prognostic factor in chronic lymphocytic leukemia.
-
CLL cell apoptosis induced by nitric oxide synthase inhibitors: correlation with lipid solubility and NOS1 dissociation constant.
-
Carcinogenicity of inhaled benzene in CBA mice.
-
Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.
-
Chronic lymphocytic leukemia cell CD38 expression and inducible nitric oxide synthase expression are associated with serum IL-4 levels.
-
Chronic lymphocytic leukemia in African Americans.
-
Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015.
-
Clinical and biological relevance of genomic heterogeneity in chronic lymphocytic leukemia.
-
Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia.
-
Clinical aspects of monoclonal B-cell lymphocytosis.
-
Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families.
-
Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes.
-
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia.
-
Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases.
-
Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.
-
Detection of trisomy 12 by fluorescence in situ hybridization on archival cytopathologic material in chronic lymphocytic leukemia/small lymphocytic lymphoma.
-
Diagnostic and clinical considerations in concomitant bone marrow involvement by plasma cell myeloma and chronic lymphocytic leukemia/monoclonal B-cell lymphocytosis: a series of 15 cases and review of literature.
-
Double IGHV DNA gene rearrangements in CLL: influence of mixed-mutated and -unmutated rearrangements on outcomes in CLL.
-
Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody.
-
Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells.
-
Fulminant hepatic failure due to disseminated adenovirus infection in a patient with chronic lymphocytic leukemia.
-
Genetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic Leukemia.
-
Genetic susceptibility variants for chronic lymphocytic leukemia.
-
Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL.
-
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.
-
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.
-
Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia.
-
Genomic stratification for the treatment of lymphomas.
-
Highlights from the 46 th annual meeting of the American Society of Hematology.
-
Histiocytic/dendritic cell transformation of B-cell neoplasms: pathologic evidence of lineage conversion in differentiated hematolymphoid malignancies.
-
IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria.
-
IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells.
-
IgG4-related tubulointerstitial nephritis associated with chronic lymphocytic leukemia.
-
Immunoglobulin class switch recombination in chronic lymphocytic leukemia.
-
Immunologic aspects of monoclonal B-cell lymphocytosis.
-
Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL.
-
Individualizing treatment decisions for older adults with hematologic malignancies.
-
Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.
-
Intensive chemotherapy for progressive chronic lymphocytic leukemia administered early after a nonmyeloablative allograft.
-
LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells.
-
Lipids and Their Effects in Chronic Lymphocytic Leukemia.
-
Malignant (Diffuse) Mesothelioma in Patients With Hematologic Malignancies: A Clinicopathologic Study of 45 Cases.
-
Mantle zone lymphoma in a gastric glomus tumor.
-
Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes.
-
Merkel cell carcinoma with partial B-cell blastic immunophenotype: a potential mimic of cutaneous richter transformation in a patient with chronic lymphocytic lymphoma.
-
Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.
-
Metachronous/concomitant B-cell neoplasms with discordant light-chain or heavy-chain isotype restrictions: evidence of distinct B-cell neoplasms rather than clonal evolutions.
-
MicroRNA antagonism of the picornaviral life cycle: alternative mechanisms of interference.
-
Monoclonal B cell lymphocytosis.
-
NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017.
-
Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes.
-
Non-Hodgkin's lymphomas, version 1.2013.
-
Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trial.
-
Oligoclonal TRBV gene usage among CD8(+) T cells in monoclonal B lymphocytosis and CLL.
-
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients.
-
Patterns of microRNA expression characterize stages of human B-cell differentiation.
-
Perifosine as a potential novel anti-telomerase therapy.
-
Perifosine treatment in chronic lymphocytic leukemia: results of a phase II clinical trial and in vitro studies.
-
Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia.
-
Pre-clinical evaluation of SN-38 and novel camptothecin analogs against human chronic B-cell lymphocytic leukemia lymphocytes.
-
Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification.
-
Progressive outer retinal necrosis.
-
Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.
-
Regulation of leukocyte adhesion molecule-1 (TQ1, Leu-8) expression and shedding by normal and malignant cells.
-
Relationship of blood monocytes with chronic lymphocytic leukemia aggressiveness and outcomes: a multi-institutional study.
-
Renal lymphoma in an azotemic patient--usefulness of magnetic resonance imaging.
-
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.
-
SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target.
-
Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion.
-
Single nucleotide polymorphisms and inherited risk of chronic lymphocytic leukemia among African Americans.
-
Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis.
-
Small lymphocytic lymphoma presenting as a paraneoplastic syndrome with acute central nervous system demyelination.
-
Suppression of Glut1 and Glucose Metabolism by Decreased Akt/mTORC1 Signaling Drives T Cell Impairment in B Cell Leukemia.
-
Telomerase activity in normal leukocytes and in hematologic malignancies.
-
The American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base report on age, gender, treatment, and outcomes of patients with chronic lymphocytic leukemia.
-
The immunologic approach to analysis of malignant lymphoma. Mantle zone lymphoma of the ileocecal region.
-
The impact of the host on fungal infections.
-
Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
-
Treatment options for newly diagnosed patients with chronic lymphocytic leukemia.
-
Use of polyethylene glycol-modified uricase (PEG-uricase) to treat hyperuricemia in a patient with non-Hodgkin lymphoma.
-
Use of serum-free media to minimize apoptosis of chronic lymphocytic leukemia cells during in vitro culture.
-
Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma.
-
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study.
-
Virtual bronchoscopy for directing transbronchial needle aspiration of hilar and mediastinal lymph nodes: a pilot study.
-
p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.
-
Keywords of People